Business Description
Founded in 2000 and based in Seongnam-si, South Korea, HLB Therapeutics is a life sciences company that researches and develops medicines both domestically and abroad. The company is working on two key drug candidates: one targeting eye conditions such as dry eye syndrome and neurotrophic keratopathy, and another aimed at treating glioblastoma, an aggressive form of brain cancer. Beyond drug development, HLB Therapeutics also distributes vaccines and produces electrical components including motors, pumps, and transformers.
